BlackRock Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$4.33M Buy
287,051
+2,461
+0.9% +$37.1K ﹤0.01% 1150
2016
Q3
$4.34M Sell
284,590
-973,320
-77% -$14.8M ﹤0.01% 1127
2016
Q2
$48.8M Sell
1,257,910
-12,062
-0.9% -$468K 0.05% 296
2016
Q1
$35.3M Buy
1,269,972
+70,929
+6% +$1.97M 0.04% 379
2015
Q4
$64.5M Buy
1,199,043
+19,938
+2% +$1.07M 0.07% 269
2015
Q3
$47.2M Buy
1,179,105
+468,445
+66% +$18.8M 0.05% 304
2015
Q2
$22.7M Sell
710,660
-422,410
-37% -$13.5M 0.02% 478
2015
Q1
$27.1M Buy
1,133,070
+161,830
+17% +$3.86M 0.03% 455
2014
Q4
$17.1M Sell
971,240
-3,925
-0.4% -$69.3K 0.02% 595
2014
Q3
$13.4M Sell
975,165
-91,369
-9% -$1.25M 0.01% 678
2014
Q2
$18M Buy
1,066,534
+5,387
+0.5% +$90.8K 0.02% 587
2014
Q1
$19.3M Buy
+1,061,147
New +$19.3M 0.02% 552